Back To Search Instructions
8 protocols meet the specified criteria
Phase: 1
Protocol No.TitleStatus
1100000082Phase I Dose Escalation Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab in Stage IV Non-Squamous Non- Small Cell Lung CancerOpen
1100000353A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (M12-175) Open
1300000483Chronic Oral Bicarbonate Feasibility StudyOpen
1300000486M13-835: An Extension Study of ABT-199 in Subjects with Advanced Non-Hodgkin's LymphomaOpen
1300000612A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma Open
1300000725A Cardiac Safety Study of TH-302 in Patients with Advanced Solid Tumors Open
1300000748A Phase 1b Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Relapsed or Refractory Multiple Myeloma Subjects who are Receiving Bortezomib and Dexamethasone as their Standard Therapy Open
1406349968An early phase clinical trial to evaluate the feasibility of CEST MRI in patients with early stage breast cancer Open